ES2093041T3 - Derivados de 2-oxo-(1,8-naftiridina). - Google Patents
Derivados de 2-oxo-(1,8-naftiridina).Info
- Publication number
- ES2093041T3 ES2093041T3 ES91106040T ES91106040T ES2093041T3 ES 2093041 T3 ES2093041 T3 ES 2093041T3 ES 91106040 T ES91106040 T ES 91106040T ES 91106040 T ES91106040 T ES 91106040T ES 2093041 T3 ES2093041 T3 ES 2093041T3
- Authority
- ES
- Spain
- Prior art keywords
- substituted
- lower alkyl
- chem
- single bond
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REVELAN DERIVADOS DE NAFTIRIDINA REPRESENTADOS POR LA FORMULA (1) DONDE: X REPRESENTA HIDROGENO; ALQUILO INFERIOR; ARALQUILO; ARILO SUSTITUIDO O NO SUSTITUIDO; GRUPO HETERO-CICLICO AROMATICO SUSTITUIDO O NO SUSTITUIDO; -NR ELEVADO 1R (AL CUADRADO) DONDE R ELEVADO 1 Y R (AL CUADRADO) REPRESENTAN INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR; DONDE W REPRESENTA N O CH, Z REPRESENTA UN ENLACE SENCILLO, OXIGENO O NR ELEVADO 3 (DONDE R ELEVADO 3 REPRESENTA HIDROGENO, ALQUILO INFERIOR O BENCILO) Y N1 Y N2 REPRESENTAN UN NUMERO ENTERO DE 1 A 3; O UN TIAZOLINILO SUSTITUIDO O NO SUSTITUIDO; Y Y ES UN ENLACE SENCILLO O ALQUILENO Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. LOS COMPUESTOS MUESTRAN UNA GRAN ACTIVIDAD ANTI-INFLAMATORIA Y SE ESPERA QUE SEAN UTILES EN EL TRATAMIENTO DE LA ARTRITIS REUMATICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10000690 | 1990-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2093041T3 true ES2093041T3 (es) | 1996-12-16 |
Family
ID=14262483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91106040T Expired - Lifetime ES2093041T3 (es) | 1990-04-16 | 1991-04-16 | Derivados de 2-oxo-(1,8-naftiridina). |
Country Status (9)
Country | Link |
---|---|
US (1) | US5126341A (es) |
EP (1) | EP0452873B1 (es) |
JP (1) | JP2988739B2 (es) |
AT (1) | ATE140003T1 (es) |
CA (1) | CA2040517C (es) |
DE (1) | DE69120581T2 (es) |
DK (1) | DK0452873T3 (es) |
ES (1) | ES2093041T3 (es) |
GR (1) | GR3020848T3 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
GB9127252D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
DE4227747A1 (de) * | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
GB9312891D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
GB9318931D0 (en) * | 1993-09-14 | 1993-10-27 | Boots Co Plc | Therapeutic agents |
GB9409264D0 (en) * | 1994-05-10 | 1994-06-29 | Boots Co Ltd | Therapeutic agents |
GB9420168D0 (en) * | 1994-10-06 | 1994-11-23 | Boots Co Plc | Therapeutic agents |
GB9420172D0 (en) * | 1994-10-06 | 1994-11-23 | Boots Co Plc | Therapeutic agents |
AU2002222683B9 (en) | 2000-12-18 | 2021-12-23 | Institute Of Medicinal Molecular Design, Inc | Inflammatory cytokine release inhibitor |
DE10222895A1 (de) * | 2002-05-23 | 2003-12-11 | Bosch Gmbh Robert | Hochdruckspeicher für Kraftstoffeinspritzsysteme mit integriertem Druckregelventil |
WO2003103648A1 (ja) * | 2002-06-05 | 2003-12-18 | 株式会社医薬分子設計研究所 | 糖尿病治療薬 |
CA2487891A1 (en) * | 2002-06-05 | 2003-12-18 | Institute Of Medicinal Molecular Design, Inc. | Inhibitors against the activation of ap-1 and nfat |
TW200407112A (en) * | 2002-06-05 | 2004-05-16 | Inst Med Molecular Design Inc | Immunity-related protein kinase inhibitors |
JP4743382B2 (ja) | 2002-06-06 | 2011-08-10 | 株式会社医薬分子設計研究所 | O−置換ヒドロキシアリール誘導体 |
JP4660674B2 (ja) * | 2002-06-06 | 2011-03-30 | 株式会社医薬分子設計研究所 | 抗アレルギー薬 |
AU2003242098B2 (en) * | 2002-06-10 | 2008-11-20 | Institute Of Medicinal Molecular Design, Inc | Inhibitors against activation of NFkappaB |
JPWO2003103655A1 (ja) * | 2002-06-10 | 2005-10-06 | 株式会社医薬分子設計研究所 | 癌治療剤 |
CA2488979A1 (en) * | 2002-06-11 | 2003-12-18 | Institute Of Medicinal Molecular Design, Inc. | Medicament for treatment of neurodegenerative diseases |
EP1561978B1 (en) * | 2002-11-12 | 2008-04-09 | Nok Corporation | Rubber-like elastic part |
EP2097416B1 (en) * | 2006-12-18 | 2012-09-12 | Amgen, Inc | Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
CA2672656C (en) * | 2006-12-18 | 2012-03-20 | Amgen Inc. | Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
US8048894B2 (en) * | 2007-04-18 | 2011-11-01 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
WO2008130508A1 (en) * | 2007-04-18 | 2008-10-30 | Amgen Inc. | Indanone derivatives that inhibit prolyl hydroxylase |
AU2008248234B2 (en) * | 2007-05-04 | 2011-02-03 | Amgen Inc. | Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
AU2008248165B2 (en) * | 2007-05-04 | 2011-12-08 | Amgen Inc. | Diazaquinolones that inhibit prolyl hydroxylase activity |
WO2013152065A2 (en) * | 2012-04-05 | 2013-10-10 | Boehringer Ingelheim International Gmbh | Cytomegalovirus inhibitor compounds |
JP2023526783A (ja) | 2020-05-05 | 2023-06-23 | テオン セラピューティクス,インク. | カンナビノイド受容体2型(cb2)調節物質及びその使用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
US4264602A (en) * | 1975-08-15 | 1981-04-28 | Sandoz, Inc. | 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones |
DE2635216A1 (de) * | 1975-08-15 | 1977-03-03 | Sandoz Ag | 4-hydorxy-3-nitropyrido eckige klammer auf 2,3-b eckige klammer zu pyridin2-one und ihre herstellung |
US4128649A (en) * | 1977-06-29 | 1978-12-05 | Sandoz, Inc. | 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters |
US4215123A (en) * | 1979-05-07 | 1980-07-29 | American Home Products Corporation | Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
DE3368929D1 (de) * | 1982-04-26 | 1987-02-12 | Schering Corp | 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives |
CA1305478C (en) * | 1986-11-06 | 1992-07-21 | Margaret H. Sherlock | Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof |
-
1991
- 1991-04-11 JP JP3079280A patent/JP2988739B2/ja not_active Expired - Fee Related
- 1991-04-12 US US07/684,214 patent/US5126341A/en not_active Expired - Fee Related
- 1991-04-15 CA CA002040517A patent/CA2040517C/en not_active Expired - Fee Related
- 1991-04-16 DK DK91106040.8T patent/DK0452873T3/da active
- 1991-04-16 AT AT91106040T patent/ATE140003T1/de not_active IP Right Cessation
- 1991-04-16 DE DE69120581T patent/DE69120581T2/de not_active Expired - Fee Related
- 1991-04-16 EP EP91106040A patent/EP0452873B1/en not_active Expired - Lifetime
- 1991-04-16 ES ES91106040T patent/ES2093041T3/es not_active Expired - Lifetime
-
1996
- 1996-08-22 GR GR960402205T patent/GR3020848T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69120581D1 (de) | 1996-08-08 |
CA2040517C (en) | 1997-06-03 |
JP2988739B2 (ja) | 1999-12-13 |
GR3020848T3 (en) | 1996-11-30 |
CA2040517A1 (en) | 1991-10-17 |
EP0452873B1 (en) | 1996-07-03 |
DE69120581T2 (de) | 1996-10-31 |
ATE140003T1 (de) | 1996-07-15 |
EP0452873A1 (en) | 1991-10-23 |
US5126341A (en) | 1992-06-30 |
DK0452873T3 (da) | 1996-07-29 |
JPH04217981A (ja) | 1992-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2093041T3 (es) | Derivados de 2-oxo-(1,8-naftiridina). | |
NO174711C (no) | Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater | |
FI875502A (fi) | Morfolinoetylester av mykofenolsyra och dess derivat | |
DK0625977T3 (da) | Piperazinderivater som 5-1A-antagonister | |
FI892497A (fi) | Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi | |
ATE99295T1 (de) | Benzimidazol-derivate mit pharmakologischer aktivitaet. | |
DK0916651T3 (da) | Phenylalkylcarboxylsyrederivater | |
DK0459505T3 (da) | Imidazonaphthyridinderivater | |
IS3828A (is) | Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar | |
DE3864707D1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
DK0417790T3 (da) | S-triazolo(3,4-i)purin-derivater | |
IT1216522B (it) | Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione. | |
DE69128272D1 (de) | Piperazinderivate | |
NO893039D0 (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 452873 Country of ref document: ES |